• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Should cefepime be used for any bloodstream infections caused by ceftriaxone-resistant, cefepime-susceptible Enterobacterales?

作者信息

Huang Joanne, Winkler Marisa L, Monk Miranda, Letourneau Alyssa R, Elshaboury Ramy H

机构信息

Department of Pharmacy, Massachusetts General Hospital, Boston, MA, USA; Department of Pharmacy, UW Medicine, Valley Medical Center, Renton, WA, USA.

Department of Medicine, Harvard Medical School, Boston, MA, USA; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA.

出版信息

Int J Antimicrob Agents. 2023 Sep;62(3):106912. doi: 10.1016/j.ijantimicag.2023.106912. Epub 2023 Jul 5.

DOI:10.1016/j.ijantimicag.2023.106912
PMID:37419293
Abstract
摘要

相似文献

1
Should cefepime be used for any bloodstream infections caused by ceftriaxone-resistant, cefepime-susceptible Enterobacterales?对于由对头孢曲松耐药但对头孢吡肟敏感的肠杆菌科细菌引起的血流感染，是否应使用头孢吡肟？
Int J Antimicrob Agents. 2023 Sep;62(3):106912. doi: 10.1016/j.ijantimicag.2023.106912. Epub 2023 Jul 5.
2
Outcomes associated with empiric cefepime for bloodstream infections caused by ceftriaxone-resistant, cefepime-susceptible Escherichia coli and Klebsiella pneumoniae.头孢吡肟经验性治疗对头孢曲松耐药、头孢吡肟敏感的大肠埃希菌和肺炎克雷伯菌血流感染的结局。
Int J Antimicrob Agents. 2023 May;61(5):106762. doi: 10.1016/j.ijantimicag.2023.106762. Epub 2023 Feb 18.
3
Multicenter surveillance of activities of cefepime-zidebactam, cefepime-enmetazobactam, omadacycline, eravacycline, and comparator antibiotics against , and complex causing bloodstream infection in Taiwan, 2020.2020 年台湾地区多中心监测头孢吡肟-齐他培南、头孢吡肟-恩他培南、奥马环素、依拉环素及对照抗生素对血流感染的 和 复合体的活性。
Expert Rev Anti Infect Ther. 2022 Jun;20(6):941-953. doi: 10.1080/14787210.2022.2021876. Epub 2022 Jan 11.
4
Compassionate use of a novel β-lactam enhancer-based investigational antibiotic cefepime/zidebactam (WCK 5222) for the treatment of extensively-drug-resistant NDM-expressing Pseudomonas aeruginosa infection in an intra-abdominal infection-induced sepsis patient: a case report.新型β-内酰胺酶增强剂研究用抗生素头孢吡肟/齐他培南（WCK 5222）治疗产 NDM 广泛耐药铜绿假单胞菌感染所致腹腔感染相关性脓毒症患者的同情用药：一例报告。
Ann Clin Microbiol Antimicrob. 2023 Jul 5;22(1):55. doi: 10.1186/s12941-023-00606-x.
5
In Vivo Evolution of CMY-2 to CMY-33 β-Lactamase in Escherichia coli Sequence Type 131: Characterization of an Acquired Extended-Spectrum AmpC Conferring Resistance to Cefepime.大肠杆菌序列型131中CMY-2向CMY-33β-内酰胺酶的体内进化：一种获得性超广谱AmpC对头孢吡肟耐药性的特征分析
Antimicrob Agents Chemother. 2015 Dec;59(12):7483-8. doi: 10.1128/AAC.01804-15. Epub 2015 Sep 21.
6
Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).针对儿科患者分离出的细菌进行的肠外广谱头孢菌素比较：哨兵抗菌监测计划（1998 - 2004年）报告
Diagn Microbiol Infect Dis. 2007 Jan;57(1):109-16. doi: 10.1016/j.diagmicrobio.2006.06.011. Epub 2006 Aug 23.
7
Antimicrobial activity of high-dose cefepime-tazobactam (WCK 4282) against a large collection of gram-negative organisms collected worldwide in 2018 and 2019.2018 年和 2019 年全世界收集的大量革兰氏阴性菌对高剂量头孢吡肟-他唑巴坦（WCK 4282）的抗菌活性。
Int J Infect Dis. 2022 Mar;116:306-312. doi: 10.1016/j.ijid.2022.01.029. Epub 2022 Jan 20.
8
Clinical exposure-response relationship of cefepime/taniborbactam against Gram-negative organisms in the murine complicated urinary tract infection model.头孢吡肟/他唑巴坦对小鼠复杂性尿路感染模型中革兰氏阴性菌的临床暴露-反应关系。
J Antimicrob Chemother. 2022 Feb 2;77(2):443-447. doi: 10.1093/jac/dkab405.
9
Cefepime for Ceftriaxone-Resistant Enterobacterales With Chromosomal AmpC β-Lactamases.
Clin Infect Dis. 2023 Jul 5;77(1):162-163. doi: 10.1093/cid/ciad173.
10
Cefepime/tazobactam compared with other tazobactam combinations against problem Gram-negative bacteria.头孢吡肟/他唑巴坦与其他他唑巴坦联合用药针对难治革兰氏阴性菌的比较。
Int J Antimicrob Agents. 2021 May;57(5):106318. doi: 10.1016/j.ijantimicag.2021.106318. Epub 2021 Mar 11.